Patents by Inventor Andrew Nickell

Andrew Nickell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9663440
    Abstract: This invention describes processes to make products by cross metathesis of functionalized or non-functionalized olefins with poly-branched poly-olefins such as terpenes (e.g., farnesene(s), ?-farnesene, ?-farnesene, ?-myrcene, etc.) and compositions made by such methods.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: May 30, 2017
    Assignee: MATERIA, INC.
    Inventors: Adam M. Johns, Richard L. Pederson, Rosemary Conrad Kiser, Andrew Nickel
  • Publication number: 20160107980
    Abstract: This invention describes processes to make products by cross metathesis of functionalized or non-functionalized olefins with poly-branched poly-olefins such as terpenes (e.g., farnesene(s), ?-farnesene, ?-farnesene, ?-myrcene, etc.) and compositions made by such methods.
    Type: Application
    Filed: April 9, 2014
    Publication date: April 21, 2016
    Inventors: Adam M. JOHNS, Richard L. PEDERSON, Rosemary Conrad KISER, Andrew NICKEL
  • Patent number: 9024116
    Abstract: The invention relates to the soybean variety designated A1035957. Provided by the invention are the seeds, plants and derivatives of the soybean variety A1035957. Also provided by the invention are tissue cultures of the soybean variety A1035957 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety A1035957 with itself or another soybean variety and plants produced by such methods.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: May 5, 2015
    Assignee: Monsanto Technology LLC
    Inventors: Andrew Nickell, Christiana Wiebbecke
  • Publication number: 20140173766
    Abstract: The invention relates to the soybean variety designated A1035957. Provided by the invention are the seeds, plants and derivatives of the soybean variety A1035957. Also provided by the invention are tissue cultures of the soybean variety A1035957 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety A1035957 with itself or another soybean variety and plants produced by such methods.
    Type: Application
    Filed: December 18, 2012
    Publication date: June 19, 2014
    Applicant: Monsanto Technology LLC
    Inventors: Andrew Nickell, Christiana Wiebbecke
  • Patent number: 8722688
    Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: May 13, 2014
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kap-Sun Yeung, Kyle E. Parcella, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, John F. Kadow, Andrew Nickel
  • Patent number: 8536338
    Abstract: The disclosure provides compounds of formula I, II, III, IV, and V, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: September 17, 2013
    Assignee: Bristol-Myers Squibb Company
    Inventors: Richard Pracitto, John F. Kadow, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, Andrew Nickel, Kyle E. Parcella, Kap-Sun Yeung, Louis S. Chupak
  • Publication number: 20120316126
    Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Application
    Filed: August 17, 2012
    Publication date: December 13, 2012
    Inventors: Kap-Sun Yeung, Kyle E. Parcella, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, John F. Kadow, Andrew Nickel
  • Patent number: 8314295
    Abstract: The invention relates to the soybean variety designated D5624041. Provided by the invention are the seeds, plants and derivatives of the soybean variety D5624041. Also provided by the invention are tissue cultures of the soybean variety D5624041 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety D5624041 with itself or another soybean variety and plants produced by such methods.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: November 20, 2012
    Assignee: Monsanto Technology LLC
    Inventors: James Behm, Brian Boston, Thomas Floyd, Alejandro Hernandez, Richard Leitz, Craig Moots, Andrew Nickell, Charlotte Sartell
  • Patent number: 8309558
    Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Grant
    Filed: February 13, 2012
    Date of Patent: November 13, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kap-Sun Yeung, Kyle E. Parcella, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, John F. Kadow, Andrew Nickel
  • Patent number: 8293909
    Abstract: The disclosure provides compounds of formula I, II, III, IV, and V, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: October 23, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: Richard Pracitto, John F. Kadow, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, Andrew Nickel, Kyle E. Parcella, Kap-Sun Yeung, Louis S. Chupak
  • Publication number: 20120232099
    Abstract: The disclosure provides compounds of formula I, II, III, IV, and V, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Application
    Filed: May 14, 2012
    Publication date: September 13, 2012
    Inventors: Richard Pracitto, John F. Kadow, John A. Bender, Brett R. Beno, Katherine A. Grant-Young, Ying Han, Piyasena Hewawasam, Andrew Nickel, Kyle E. Parcella, Kap-Sun Yeung, Louis S. Chupak
  • Publication number: 20120201783
    Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Application
    Filed: February 13, 2012
    Publication date: August 9, 2012
    Inventors: Kap-Sun Yeung, Kyle E. Parcella, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, John F. Kadow, Andrew Nickel
  • Patent number: 8207404
    Abstract: The invention relates to the soybean variety designated D5365424. Provided by the invention are the seeds, plants and derivatives of the soybean variety D5365424. Also provided by the invention are tissue cultures of the soybean variety D5365424 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety D5365424 with itself or another soybean variety and plants produced by such methods.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: June 26, 2012
    Assignee: Monsanto Technology LLC
    Inventors: James Behm, Brian Boston, Thomas Floyd, Alejandro Hernandez, Richard Leitz, Craig Moots, Andrew Nickell, Charlotte Sartell
  • Patent number: 8207405
    Abstract: The invention relates to the soybean variety designated D5234214. Provided by the invention are the seeds, plants and derivatives of the soybean variety D5234214. Also provided by the invention are tissue cultures of the soybean variety D5234214 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety D5234214 with itself or another soybean variety and plants produced by such methods.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: June 26, 2012
    Assignee: Monsanto Technology LLC
    Inventors: James Behm, Brian Boston, Thomas Floyd, Alejandro Hernandez, Richard Leitz, Craig Moots, Andrew Nickell
  • Patent number: 8198449
    Abstract: The disclosure provides compounds of formula I, II, III, IV, and V, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: June 12, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: Richard Pracitto, John F. Kadow, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, Andrew Nickel, Kyle E. Parcella, Kap-Sun Yeung, Louis S. Chupak
  • Patent number: 8158863
    Abstract: The invention relates to the soybean variety designated D5214244. Provided by the invention are the seeds, plants and derivatives of the soybean variety D5214244. Also provided by the invention are tissue cultures of the soybean variety D5214244 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety D5214244 with itself or another soybean variety and plants produced by such methods.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: April 17, 2012
    Assignee: Monsanto Technology LLC
    Inventors: James Behm, Brian Boston, Thomas Floyd, Alejandro Hernandez, Richard Leitz, Craig Moots, Andrew Nickell
  • Patent number: 8148382
    Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: April 3, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kap-Sun Yeung, Kyle E. Parcella, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, John F. Kadow, Andrew Nickel
  • Patent number: 8048887
    Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Grant
    Filed: September 4, 2009
    Date of Patent: November 1, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kap-Sun Yeung, Kyle E. Parcella, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, John F. Kadow, Andrew Nickel
  • Publication number: 20110256099
    Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Application
    Filed: June 23, 2011
    Publication date: October 20, 2011
    Inventors: Kap-Sun Yeung, Kyle E. Parcella, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, John F. Kadow, Andrew Nickel
  • Publication number: 20110239320
    Abstract: The invention relates to the soybean variety designated D5624041. Provided by the invention are the seeds, plants and derivatives of the soybean variety D5624041. Also provided by the invention are tissue cultures of the soybean variety D5624041 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety D5624041 with itself or another soybean variety and plants produced by such methods.
    Type: Application
    Filed: March 26, 2010
    Publication date: September 29, 2011
    Inventors: James BEHM, Brian Boston, Thomas Floyd, Alejandro Hernandez, Richard Leitz, Craig Moots, Andrew Nickell, Charlotte Sartell